CUSIP 45168D104 · who reports it, how much, and how much it matters to them
44 of the 720 hedge fund managers we track reported shares of Idexx Laboratories Inc (Nasdaq: IDXX) on Form 13F for 30 June 2026. Between them they reported USD 780m. The largest position belongs to Squarepoint Ops, at USD 166m. The manager with the most riding on it is Fora Capital, where it is 1.4% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Squarepoint Ops7 funds on PPLI.com | USD 166m | 0.2% |
| 2 | POINT72 Asset Management17 funds on PPLI.com | USD 138m | 0.2% |
| 3 | Holocene Advisors2 funds on PPLI.com | USD 92m | 0.2% |
| 4 | Renaissance Technologies13 funds on PPLI.com | USD 58m | 0.1% |
| 5 | Marshall Wace LLP84 funds on PPLI.com | USD 49m | 0.0% |
| 6 | Millennium Management6 funds on PPLI.com | USD 42m | 0.0% |
| 7 | Adage Capital Management1 fund on PPLI.com | USD 37m | 0.1% |
| 8 | Freestone Grove Partners1 fund on PPLI.com | USD 32m | 0.2% |
| 9 | Citadel Advisors32 funds on PPLI.com | USD 20m | 0.0% |
| 10 | Fora Capital1 fund on PPLI.com | USD 20m | 1.4% |
| 11 | CIBC Asset Management69 funds on PPLI.com | USD 19m | 0.0% |
| 12 | Capital Fund Management S.A.12 funds on PPLI.com | USD 18m | 0.1% |
| 13 | Bridgewater Associates45 funds on PPLI.com | USD 18m | 0.1% |
| 14 | IFM Investors Pty7 funds on PPLI.com | USD 10m | 0.1% |
| 15 | Exoduspoint Capital Management7 funds on PPLI.com | USD 6.8m | 0.0% |
| 16 | Voleon Capital Management13 funds on PPLI.com | USD 5.8m | 0.1% |
| 17 | Brevan Howard Capital Management39 funds on PPLI.com | USD 5.6m | 0.0% |
| 18 | Landscape Capital Management4 funds on PPLI.com | USD 4.8m | 0.3% |
| 19 | Farallon Capital Management56 funds on PPLI.com | USD 4.7m | 0.0% |
| 20 | Brant Point Investment Management3 funds on PPLI.com | USD 4.7m | 0.6% |
| 21 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 4.1m | 0.0% |
| 22 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 3.1m | 0.2% |
| 23 | Engineers Gate Manager1 fund on PPLI.com | USD 2.7m | 0.0% |
| 24 | Kinneret Advisory7 funds on PPLI.com | USD 2.7m | 0.2% |
| 25 | LMR Partners2 funds on PPLI.com | USD 2.7m | 0.0% |
| 26 | Platinum Investment Management11 funds on PPLI.com | USD 1.5m | 0.4% |
| 27 | Aquatic Capital Management3 funds on PPLI.com | USD 1.4m | 0.0% |
| 28 | Boothbay Fund Management2 funds on PPLI.com | USD 1.4m | 0.0% |
| 29 | Grandeur Peak Global Advisors2 funds on PPLI.com | USD 1.2m | 0.3% |
| 30 | Magnetar Financial93 funds on PPLI.com | USD 968,000 | 0.0% |
| 31 | Balyasny Asset Management25 funds on PPLI.com | USD 952,000 | 0.0% |
| 32 | Trust Asset Management4 funds on PPLI.com | USD 847,000 | 0.0% |
| 33 | Fulcrum Asset Management LLP7 funds on PPLI.com | USD 565,000 | 0.1% |
| 34 | Oxford Asset Management LLP2 funds on PPLI.com | USD 565,000 | 0.3% |
| 35 | Two Sigma Investments35 funds on PPLI.com | USD 537,000 | 0.0% |
| 36 | Graham Capital Management18 funds on PPLI.com | USD 463,000 | 0.0% |
| 37 | Prelude Capital Management9 funds on PPLI.com | USD 426,000 | 0.0% |
| 38 | Hudson Bay Capital Management8 funds on PPLI.com | USD 358,000 | 0.0% |
| 39 | Entrypoint Capital1 fund on PPLI.com | USD 334,000 | 0.1% |
| 40 | ISAM Funds (UK)1 fund on PPLI.com | USD 295,000 | 0.2% |
| 41 | Prescott Group Capital Management3 funds on PPLI.com | USD 234,000 | 0.0% |
| 42 | Bayforest Capital1 fund on PPLI.com | USD 117,000 | 0.1% |
| 43 | The Quarry1 fund on PPLI.com | USD 81,071 | 0.0% |
| 44 | Persistent Asset Partners10 funds on PPLI.com | USD 2,632 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Fora Capital | USD 20m | 1.4% |
| 2 | Brant Point Investment Management | USD 4.7m | 0.6% |
| 3 | Platinum Investment Management | USD 1.5m | 0.4% |
| 4 | Landscape Capital Management | USD 4.8m | 0.3% |
| 5 | Oxford Asset Management LLP | USD 565,000 | 0.3% |
| 6 | Grandeur Peak Global Advisors | USD 1.2m | 0.3% |
| 7 | Kinneret Advisory | USD 2.7m | 0.2% |
| 8 | Holocene Advisors | USD 92m | 0.2% |
| 9 | ISAM Funds (UK) | USD 295,000 | 0.2% |
| 10 | Freestone Grove Partners | USD 32m | 0.2% |
Idexx Laboratories Inc trades under the symbol IDXX on the Nasdaq. Its CUSIP, the code used on Form 13F, is 45168D104.
44 of the 720 hedge fund managers PPLI.com tracks reported Idexx Laboratories Inc shares on Form 13F for 30 June 2026. The largest reported positions were held by Squarepoint Ops (USD 166m), POINT72 Asset Management (USD 138m), Holocene Advisors (USD 92m), Renaissance Technologies (USD 58m) and Marshall Wace LLP (USD 49m).
44 managers in our coverage reported it, and between them they run 703 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Fora Capital, where the position was 1.4% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Idexx Laboratories Inc or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.